Complete response to exemestane in a patient with a desmoid tumor.

about

Microbial transformation of anti-cancer steroid exemestane and cytotoxicity of its metabolites against cancer cell lines.Expression of estrogen and progesterone receptors across human malignancies: new therapeutic opportunities.

P2860

Q36798587-A623B68B-D6F0-4185-A67C-2353D97547E7 Q38301592-89799A4F-74B4-4F91-B1AA-C4643C1B66D4

P2860

Complete response to exemestane in a patient with a desmoid tumor.

Item

http://www.wikidata.org/entity/Q39627437

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Complete response to exemestane in a patient with a desmoid tumor.

@en

Complete response to exemestane in a patient with a desmoid tumor.

@nl

type

Item

label

Complete response to exemestane in a patient with a desmoid tumor.

@en

Complete response to exemestane in a patient with a desmoid tumor.

@nl

prefLabel

Complete response to exemestane in a patient with a desmoid tumor.

@en

Complete response to exemestane in a patient with a desmoid tumor.

@nl

P1476

Complete response to exemestane in a patient with a desmoid tumor.

@en

P2093

Antoine Italiano

http://www.w3.org/2001/XMLSchema#string

Chantal Cambon-Michot

http://www.w3.org/2001/XMLSchema#string

Franck Dujardin

http://www.w3.org/2001/XMLSchema#string

François Le Loarer

http://www.w3.org/2001/XMLSchema#string

Françoise Callonnec

http://www.w3.org/2001/XMLSchema#string

Isabelle Soubeyran

http://www.w3.org/2001/XMLSchema#string

Marc Debled

http://www.w3.org/2001/XMLSchema#string

P2860

ERbeta in breast cancer--onlooker, passive player, or active protector?

Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up.

The pharmacological treatment of aggressive fibromatosis: a systematic review.

High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.

Estrogen receptor-beta expression in extraabdominal fibromatoses: an analysis of 40 cases.

Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG).

Immunohistochemical analysis of desmoid tumours.

Hormonal therapy of endometrial stromal sarcoma.

Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer.

Early recurrence risk: aromatase inhibitors versus tamoxifen.

P304

483-486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.12.24

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22515450

http://www.w3.org/2001/XMLSchema#string

Complete response to exemestane in a patient with a desmoid tumor.

about

P2860

P2860

Complete response to exemestane in a patient with a desmoid tumor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698